FDAnews
www.fdanews.com/articles/63353-cyberkinetics-braingate-system-enables-thought-driven-communication-device-and-wheelchair-control-for-first-stroke-participant-in-pilot-clinical-trial

CYBERKINETICS' BRAINGATE SYSTEM ENABLES THOUGHT-DRIVEN COMMUNICATION DEVICE AND WHEELCHAIR CONTROL FOR FIRST STROKE PARTICIPANT IN PILOT CLINICAL TRIAL

October 16, 2006

Cyberkinetics Neurotechnology Systems, Inc. (Cyberkinetics) announced that John P. Donoghue, Ph.D., Cyberkinetics' Chief Scientific Officer, presented preliminary findings from three participants in Cyberkinetics' pilot trial of the BrainGate Neural Interface System (BrainGate) at the Annual Meeting of the Society for Neuroscience in Atlanta, Georgia. Dr. Donoghue provided preliminary scientific results related to one of the participants who is unable to move or speak due to a brainstem stroke. This participant was able to achieve BrainGate-enabled control of a communication device and to demonstrate the initial proof-of-concept of the ability to remotely operate a wheelchair using her thoughts.

Business Wire (http://home.businesswire.com/portal/site/home/?epi_menuItemID=989a6827590d7dda9cdf6023a0908a0c&epi_menuID=c791260db682611740b28e347a808a0c&epi_baseMenuID=384979e8cc48c441ef0130f5c6908a0c&ndmViewId=news_view&newsLang=en&div=294036369&newsId=20061015005018)